Sci-Tech Press Iceland
SEE OTHER BRANDS

Exploring the science and technology news of Iceland

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Press Iceland.

European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
Positive Polar Launches Wefunder Campaign to Develop Scalable Biotech with the Power to Restore Whale Population
Lucinity Featured in Chartis Research FinCrime and Compliance 50 Ranking for 2025
Operational update
Open Ocean Robotics Launches First USV for Marine CO₂ Removal Monitoring with Sales to Leading Research Institutions
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
 PureCycle Receives REACH Certification, Unlocking EU Sales of PureFive™ Resin
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Committee advances discussions on trade-related climate measures and technology transfer
State Visit from Iceland

State Visit from Iceland

SWEDEN, March 19 - On 6–8 May 2025, Iceland’s President Halla Tómasdóttir will pay a State Visit to Sweden at the invitation of His Majesty The King. Ms Tómasdóttir will be accompanied by her husband, Björn Skúlason, and representatives of the...

Owner:  Swedish Government
The International Myeloma Foundation Announces 2nd Annual Iceland Cycling Expedition, to be Held from August 27 – September 2
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
Tilde enters the global AI race with a European multilingual model and safeguards against disinformation
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
Bellame Expands Global Shipping to 17 Countries and Introduces 7-Day-a-Week Fulfillment to Meet Rising Demand
What if? “Strategic Competition” vs. “Selective Cooperation”
Iceland deploys its first fully funded UN Volunteer in India

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions